Insider Trades24 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 10,000 | $40.00 | $2.1B | -16.73% | +166.77% | $400.0K | -7.71% | 10b5-1 | Stalk |
| Jun 22, 2026 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 10,000 | $35.01 | $2.1B | -16.73% | +166.77% | $350.1K | -7.15% | 10b5-1 | Stalk |
| Jun 8, 2026 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 5,222 | $27.30 | $2.1B | -16.73% | +166.77% | $142.6K | -3.60% | — | Stalk |
| May 8, 2026 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 10,000 | $30.00 | $2.1B | -16.73% | +166.77% | $300.0K | -6.90% | 10b5-1 | Stalk |
| Feb 3, 2026 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 7,373 | $19.69 | $2.1B | -16.73% | +166.77% | $145.2K | -1.63% | — | Stalk |
| Feb 3, 2026 | Sell | URGN | Jason Drew Smith | General Counsel | 7,479 | $19.69 | $2.1B | -16.73% | +166.77% | $147.3K | -3.53% | — | Stalk |
| Nov 19, 2025 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 10,000 | $25.00 | $2.1B | -16.73% | +166.77% | $250.0K | -6.71% | 10b5-1 | Stalk |
| Oct 8, 2025 | Sell | URGN | Chris Degnan | Chief Financial Officer | 2,203 | $16.85 | $2.1B | -16.73% | +166.77% | $37.1K | -16.38% | — | Stalk |
| Sep 8, 2025 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 871 | $19.11 | $2.1B | -16.73% | +166.77% | $16.6K | -0.57% | — | Stalk |
| Sep 8, 2025 | Sell | URGN | Jason Drew Smith | General Counsel | 1,520 | $19.11 | $2.1B | -16.73% | +166.77% | $29.0K | -3.16% | — | Stalk |
| Aug 11, 2025 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 10,000 | $17.69 | $2.1B | -16.73% | +166.77% | $176.9K | -6.32% | — | Stalk |
| Jul 28, 2025 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 5,149 | $19.14 | $2.1B | -16.73% | +166.77% | $98.6K | -3.15% | — | Stalk |
| Jul 28, 2025 | Sell | URGN | Jason Drew Smith | General Counsel | 7,522 | $19.14 | $2.1B | -16.73% | +166.77% | $144.0K | -15.35% | — | Stalk |
| Jun 9, 2025 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 5,162 | $7.37 | $2.1B | -16.73% | +166.77% | $38.0K | -3.06% | — | Stalk |
| Jan 31, 2025 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 4,551 | $11.14 | $2.1B | -16.73% | +166.77% | $50.7K | -0.96% | — | Stalk |
| Jan 31, 2025 | Sell | URGN | Jason Drew Smith | General Counsel | 7,379 | $11.14 | $2.1B | -16.73% | +166.77% | $82.2K | -5.96% | — | Stalk |
| Sep 9, 2024 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 859 | $13.08 | $2.1B | -16.73% | +166.77% | $11.2K | -0.58% | — | Stalk |
| Sep 9, 2024 | Sell | URGN | Jason Drew Smith | General Counsel | 1,521 | $13.08 | $2.1B | -16.73% | +166.77% | $19.9K | -4.55% | — | Stalk |
| Jun 10, 2024 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 5,153 | $13.08 | $2.1B | -16.73% | +166.77% | $67.4K | -3.04% | — | Stalk |
| Mar 18, 2024 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 12,000 | $14.05 | $2.1B | -16.73% | +166.77% | $168.6K | -7.92% | — | Stalk |
| Feb 1, 2024 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 3,789 | $15.78 | $2.1B | -16.73% | +166.77% | $59.8K | -0.83% | — | Stalk |
| Feb 1, 2024 | Sell | URGN | Jason Drew Smith | General Counsel | 4,993 | $15.78 | $2.1B | -16.73% | +166.77% | $78.8K | -7.42% | — | Stalk |
| Jan 31, 2024 | Sell | URGN | Mark Schoenberg | Chief Medical Officer | 3,789 | $15.74 | $2.1B | -16.73% | +166.77% | $59.6K | -0.80% | — | Stalk |
| Jan 31, 2024 | Sell | URGN | Jason Drew Smith | General Counsel | 4,993 | $15.74 | $2.1B | -16.73% | +166.77% | $78.6K | -5.01% | — | Stalk |